80
Participants
Start Date
August 31, 2005
Study Completion Date
April 30, 2009
Amonafide L-Malate
Cytarabine
Wake Forest University Health Sciences, Winston-Salem
Duke University Medical Center, Durham
MUSC - Hollings Cancer Center, Charleston
St. Francis Cancer Research Foundation (formerly Indiana Oncology Hematology Consultants and American Health Network of Indiana LLC, Oncology Division), Indianapolis
Medical College of Wisconsin, Milwaukee
Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
Roswell Park Cancer Institute, Buffalo
Baylor University Medical Center, Dallas
University of Colorado Health Sciences Center, Anschutz Cancer Center, Aurora
UCLA Medical Center, Los Angeles
City of Hope National Medical Center, Duarte
Scripps Cancer Center, San Diego
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
University of Florida Health Science Center, Gainesville
Dana Farber Cancer Institute, Boston
University of Massachusetts Memorial Medical Center, Worcester
University of Michigan, Ann Arbor
University of Nebraska Medical Center, Omaha
West Virginia University Medical Center, Morgantown
Vancouver General Hospital, Vancouver
London Regional Cancer Program, London Health Science Center, London
Xanthus Pharmaceuticals, Inc.
INDUSTRY